281 related articles for article (PubMed ID: 17351872)
1. Therapeutic success via targeted approaches and strategic partnerships with clinical laboratories.
Miller GA
IDrugs; 2007 Mar; 10(3):181-4. PubMed ID: 17351872
[TBL] [Abstract][Full Text] [Related]
2. Personalized medicine: elusive dream or imminent reality?
Lesko LJ
Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
[TBL] [Abstract][Full Text] [Related]
3. The prospects for "personalized medicine" in drug development and drug therapy.
Woodcock J
Clin Pharmacol Ther; 2007 Feb; 81(2):164-9. PubMed ID: 17259943
[TBL] [Abstract][Full Text] [Related]
4. Biosimulation software is changing research.
Ho RL; Bartsell LT
Biotechnol Annu Rev; 2004; 10():297-302. PubMed ID: 15504712
[TBL] [Abstract][Full Text] [Related]
5. The integration of molecular diagnostics with therapeutics. Implications for drug development and pathology practice.
Ross JS; Ginsburg GS
Am J Clin Pathol; 2003 Jan; 119(1):26-36. PubMed ID: 12520694
[TBL] [Abstract][Full Text] [Related]
6. Strategic groups in the biopharmaceutical industry: implications for performance.
Erden Z; von Krogh G; Nytorp C; Hultberg M
Drug Discov Today; 2009 Aug; 14(15-16):726-30. PubMed ID: 19416760
[TBL] [Abstract][Full Text] [Related]
7. Personalized medicine.
Jain KK
Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
[TBL] [Abstract][Full Text] [Related]
8. Human genome project: pharmacogenomics and drug development.
Ganguly NK; Bano R; Seth SD
Indian J Exp Biol; 2001 Oct; 39(10):955-61. PubMed ID: 11883519
[TBL] [Abstract][Full Text] [Related]
9. Cytomics and drug discovery.
Van Osta P; Ver Donck K; Bols L; Geysen J
Cytometry A; 2006 Mar; 69(3):117-8. PubMed ID: 16496374
[TBL] [Abstract][Full Text] [Related]
10. Challenges of drug discovery for personalized medicine.
Jain KK
Curr Opin Mol Ther; 2006 Dec; 8(6):487-92. PubMed ID: 17243483
[TBL] [Abstract][Full Text] [Related]
11. Big Pharma's Commedia.
Steele FR
Cell; 2005 Dec; 123(6):971-3. PubMed ID: 16360023
[No Abstract] [Full Text] [Related]
12. Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeutics.
Fitzgerald GA
Nat Rev Drug Discov; 2005 Oct; 4(10):815-8. PubMed ID: 16224453
[TBL] [Abstract][Full Text] [Related]
13. Redesigner drugs.
Dove A
Nat Biotechnol; 2004 Aug; 22(8):953-7. PubMed ID: 15286643
[TBL] [Abstract][Full Text] [Related]
14. Truly personalised medicine: self-experimentation in medical discovery.
Bains W
Med Hypotheses; 2008; 70(4):714-8. PubMed ID: 17910992
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers: a valuable tool in clinical research and medical practice.
Carini C
IDrugs; 2007 Jun; 10(6):395-8. PubMed ID: 17642003
[TBL] [Abstract][Full Text] [Related]
16. Clinical research in China and India: a paradigm shift in drug development.
Singh R
Drug Discov Today; 2006 Aug; 11(15-16):675-6. PubMed ID: 16846793
[No Abstract] [Full Text] [Related]
17. Follow-on drugs and indications: the importance of incremental innovation to medical practice.
Cohen J; Kaitin K
Am J Ther; 2008; 15(1):89-91. PubMed ID: 18223359
[No Abstract] [Full Text] [Related]
18. Molecular genetics: the Emperor's clothes of drug discovery?
Higgs G
Drug Discov Today; 2004 Sep; 9(17):727-9. PubMed ID: 15450232
[No Abstract] [Full Text] [Related]
19. Identification and development of new biopharmaceuticals.
Werner RG
Arzneimittelforschung; 1998 May; 48(5):523-30. PubMed ID: 9638321
[TBL] [Abstract][Full Text] [Related]
20. Aligning pharmaceutical innovation with medical need.
Nathan C
Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145
[No Abstract] [Full Text] [Related]
[Next] [New Search]
